US pharma tariffs: CDMOs with innovator exposure likely to take a hit (Soban News)

Proposed US tariffs on patented drugs may pressure innovators to shift production locally, creating uncertainty for Indian CDMOs even as generics-led exports remain largely insulated​Proposed US tariffs on patented drugs may pressure innovators to shift production locally, creating uncertainty for Indian CDMOs even as generics-led exports remain largely insulated ​Latest News [ SOBAN NEWS: International and National ]